Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model - Scorecard - MDSpire
Advertisement
Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model
Clinical Scorecard: Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model
At a Glance
Category
Detail
Condition
Influenza in cancer patients
Key Mechanisms
Immunosuppression due to cancer and its treatments increases risk of severe influenza complications.
Target Population
Cancer patients, particularly those undergoing treatment.
Care Setting
Tertiary care general hospitals in China.
Key Highlights
Cancer patients have a significantly higher risk of severe influenza complications compared to healthy individuals.
Influenza vaccination can reduce total mortality in cancer patients by 9% to 34%.
Vaccine hesitancy among cancer patients in China is as high as 42.06%, exceeding that of the general population.
Guideline-Based Recommendations
Diagnosis
Cancer diagnosis through histopathological or clinical examination.
Management
Administer influenza vaccination to cancer patients as a preventive measure.
Monitoring & Follow-up
Assess vaccination rates and complications post-influenza infection.
Risks
Increased risk of hospitalization and death from influenza in cancer patients.
Patient & Prescribing Data
Adults over 18 years diagnosed with cancer.
Vaccination is crucial for reducing complications and improving treatment outcomes.
Clinical Best Practices
Utilize the Health Belief Model to understand and address vaccine hesitancy.
Implement targeted interventions to increase vaccination rates among cancer patients.
